Ming Chu

Prof. Ming Chu

Peking University
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MCMing Chu
Ming Chu
MZMing-Bo Zhang
Ming-Bo Zhang
YLYan-Chen Liu
Yan-Chen Liu
JKJia-Rui Kang
Jia-Rui Kang
ZCZheng-Yun Chu
Zheng-Yun Chu
Yuedan WangYuedan Wang
Yuedan Wang
Berberine is an isoquinoline alkaloid widely used in the treatment of microbial infections. Recent studies have shown that berberine can enhance the inhibitory efficacy of antibiotics against clinical multi-drug resistant isolates of methicillin-resistantStaphylococcus aureus(MRSA). However, the underlying mechanisms are poorly understood. Here, we demonstrated that sub-minimum inhibitory concentrations (MICs) of berberine exhibited no bactericidal activity against MRSA, but affected MRSA biofilm development in a dose dependent manner within the concentration ranging from 1 to 64 μg/mL. Further study indicated that berberine inhibited MRSA amyloid fibrils formation, which consist of phenol-soluble modulins (PSMs). Molecular dynamics simulation revealed that berberine could bind with the phenyl ring of Phe19 in PSMα2 through hydrophobic interaction. Collectively, berberine can inhibit MRSA biofilm formationviaaffecting PSMs’ aggregation into amyloid fibrils and thereby enhance bactericidal activity of antibiotics. These findings will provide new insights into the multiple pharmacological properties of berberine in the treatment of microbial-generated amyloid involved diseases.

6 March 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MCMing Chu
Ming Chu
RDRan Ding
Ran Ding
ZCZheng-Yun Chu
Zheng-Yun Chu
MZMingbo Zhang
Mingbo Zhang
XLXiao-Yan Liu
Xiao-Yan Liu
Yuedan WangYuedan Wang
Yuedan Wang
Berberine is an isoquinoline alkaloid mainly extracted from Rhizoma Coptidis and has been shown to possess a potent inhibitory activity against bacterial. However, the role of berberine in anti-bacterial action has not been extensively studied.

20 May 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
ZZZhou Zhou
Zhou Zhou
YZYimiao Zhu
Yimiao Zhu
MCMing Chu
Ming Chu
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a threat to the health of the global population. As the result of a global effort in the determination of origin, structure, and pathogenesis of SARS-CoV-2 and its variants, particularly such the variant of concern as Delta Variant and Omicron Variant, the understanding of SARS-CoV-2 are deepening and the development of vaccines against SARS-CoV-2 are ongoing. Currently, AstraZeneca-Vaxzevria/SII-Covishield vaccine, Janssen-Ad26.COV2.S vaccine, Moderna-mRNA-1273 vaccine, Pfizer BioNTech-Comirnaty vaccine and Sinovac-CoronaVac vaccine have been listed as WHO Emergency Use Listing (EUL) Qualified Vaccines by WHO. Because of the antigen escape caused by the mutation in variants, the effectiveness of vaccines, which are currently the main means of prevention and treatment, has been affected by varying degrees. Herein, we review the current status of mutations of SARS-CoV-2 variants, the different approaches used in the development of COVID-19 vaccines, and COVID-19 vaccine effectiveness against SARS-CoV-2 variants.

10 December 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MCMing Chu
Ming Chu
LXLan Xu
Lan Xu
MZMing-Bo Zhang
Ming-Bo Zhang
ZCZheng-Yun Chu
Zheng-Yun Chu
Yuedan WangYuedan Wang
Yuedan Wang
Baicalin (BA) is a flavonoid compound purified fromScutellaria baicalensisGeorgi and has been shown to possess a potent inhibitory activity against viruses. However, the role of BA in anti-influenza virus has not been extensively studied, and the immunological mechanism of BA in antiviral activity remains unknown. Here, we observed that BA could protect mice from infection by influenza virus A/PR/8/34 (H1N1), associated with increasing IFN-γproduction, but presented no effects in IFN-γor IFN-γreceptor deficient mice. Further study indicated that BA could inhibit A/PR/8/34 replication through IFN-γin human PBMC. Moreover, BA can directly induce IFN-γproduction in human CD4+and CD8+T cells and NK cells, and activate JAK/STAT-1 signaling pathway. Collectively, BA exhibited anti-influenza virus A (H1N1) activityin vitroandin vivoas a potent inducer of IFN-γin major IFN-γproducing cells.

3 November 2022 in Frontiers in Microbiology
Verified
Journal Article
Open access
YLYuan Liu
Yuan Liu
WQWenting Qv
Wenting Qv
YMYinchao Ma
Yinchao Ma
YZYuying Zhang
Yuying Zhang
CDChong Ding
Chong Ding
FCFeng Chen
Feng Chen
Oral microbes play a critical role in maintaining oral homeostasis. Microbial dysbiosis promotes disease pathogenesis through several mechanisms. Recent studies have revealed that microbial imbalance and sustained inflammation are involved in disease progression. The adverse interaction triggered by a host immune response to microorganisms can lead to oral and systemic diseases. Here, we reviewed how oral microbes communicate with hosts during the development of local and distant inflammation. Elucidation of these processes may reveal future directions in this field and the potential targets of novel biological therapies for oral and systemic diseases.

25 April 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
MCMing Chu
Ming Chu
MZMingya Zhou
Mingya Zhou
CJCaihong Jiang
Caihong Jiang
XCXi Chen
Xi Chen
LGLikai Guo
Likai Guo
Yuedan WangYuedan Wang
Yuedan Wang
Phenol-soluble modulins (PSMs) have recently emerged as key virulence determinants, particularly in highly aggressive Staphylococcus aureus isolates. These peptides contribute to the pathogenesis of S. aureus infections, participating in multiple inflammatory responses. Here, we report a new role for S. aureus PSMs in high mobility group box-1 protein (HMGB1) induced inflammation by modulating toll-like receptor (TLR) 4 pathway. Direct ligation of TLR4 with S. aureus PSMα1–α3 and PSMβ1–β2 was identified by surface plasmon resonance. Remarkably, the binding affinity of TLR4 with HMGB1 was attenuated by PSMα1–α3. Further study revealed that PSMα1–α3 directly inhibited HMGB1-induced NF-κB activation and proinflammatory cytokines production in vitro using HEK-Blue hTLR4 cells and THP-1 cells. To analyze the molecular interactions between PSMs and TLR4, blast similarity search was performed and identified that PSMα1 and PSMβ2 were ideal templates for homology modeling. The three-dimensional structures of PSMα2, PSMα4, PSMβ1, and δ-toxin were successfully generated with MODELLER, and further refined using CHARMm. PSMs docking into TLR4 were done using ZDOCK, indicating that PSMα1–α3 compete with HMGB1 for interacting with the surrounding residues (336–477) of TLR4 domain. Our study reveals that S. aureus PSMα1–α3 can act as novel TLR4 antagonists, which account at least in part for the staphylococcal immune evasion. Modulation of this process will lead to new therapeutic strategies against S. aureus infections.